Is Chinook Therapeutics Inc (KDNY) Stock a Bad Value Wednesday?

Wednesday, June 14, 2023 01:57 PM | InvestorsObserver Analysts

Mentioned in this article

Is Chinook Therapeutics Inc (KDNY) Stock a Bad Value Wednesday?

Chinook Therapeutics Inc (KDNY) is around the top of the Healthcare sector according to InvestorsObserver. KDNY received an overall rating of 99, which means that it scores higher than 99% of stocks. Additionally, Chinook Therapeutics Inc scored a 76 in the Healthcare sector, ranking it higher than 76% of stocks in that sector.

KDNY has an Overall Score of 99. Find out what this means to you and get the rest of the rankings on KDNY!

See Full KDNY Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Chinook Therapeutics Inc Stock Today?

Chinook Therapeutics Inc (KDNY) stock is lower by -0.45% while the S&P 500 is higher by 0.12% as of 1:57 PM on Wednesday, Jun 14. KDNY has fallen -$0.17 from the previous closing price of $37.87 on volume of 2,605,212 shares. Over the past year the S&P 500 is up 17.10% while KDNY is higher by 134.16%. KDNY lost -$3.19 per share the over the last 12 months. Click Here to get the full Stock Report for Chinook Therapeutics Inc stock.